AAP
TELA icon

Arax Advisory Partners’s TELA Bio TELA Stock Holding History

Arax Advisory Partners’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-60
Closed -$152 – 2741
2024
Q3 		$152 Hold
60
– – ﹤0.01% 2533
2024
Q2 		$282 Buy
+60
New +$316 ﹤0.01% 2408

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Arax Advisory Partners's TELA Position: Q4 2024 in Review

Arax Advisory Partners sold out of TELA Bio (TELA) in Q4 2024, closing a stake of 60 shares — an estimated $152 sold.

Arax Advisory Partners first reported a position in TELA in Q2 2024 and held it in 2 quarters. The position peaked at $282 in Q2 2024. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2024.

  • Arax Advisory Partners reported no remaining TELA Bio position as of Q4 2024 after selling out during the quarter.
  • Arax Advisory Partners sold 60 TELA Bio shares in Q4 2024, an estimated $152.
  • Arax Advisory Partners first reported a position in TELA Bio in Q2 2024 and held it in 2 quarters.
  • Arax Advisory Partners's TELA Bio position peaked at $282 in Q2 2024.
  • 47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2024.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.